Metabolic and clinical effects of progestogens

European Journal of Contraception and Reproductive Health Care

Volumn 11, Issue 3, 2006, Pages 153-161

  Wiegratz, Inka ^a   Kuhl, Herbert ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Clinical effects; Hormonal activities; Metabolic effects; Potency; Progestogens

Indexed keywords

CHLORMADINONE ACETATE; CYPROTERONE ACETATE; DIENOGEST; DROSPIRENONE; ETONOGESTREL; GESTAGEN; GESTODENE; GLOBULIN; GROWTH HORMONE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE; NORETHISTERONE; NORGESTIMATE; PROGESTERONE; SOMATOMEDIN BINDING PROTEIN;

ARTERY DISEASE; BLOOD PRESSURE MEASUREMENT; CARBOHYDRATE METABOLISM; DIABETES MELLITUS; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; HEMOSTASIS; HORMONE ACTION; LIPID METABOLISM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; THROMBOEMBOLISM; WATER RETENTION;

CONTRACEPTIVES, ORAL, SYNTHETIC; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYPERANDROGENISM; METABOLISM; PROGESTINS; RENIN-ANGIOTENSIN SYSTEM; THROMBOEMBOLISM;

EID: 33750330492     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180600772741     Document Type: Review

References (21)

1. Kuhl H. Pharmacology of oestrogens and progestogens: influence of different routes of administration. Climacteric 2005;8(Suppl 1):3-63.
2. Benagiano G, Primiero FM, Farris M. Clinical profile of contraceptive progestins. Eur J Contracept Reprod Health Care 2004;9:182-93.
3. Bloemenkamp KWM. Epidemiology of oral contraceptive related thrombosis. Thromb Res 2005;115 (Suppl):1-6.
4. Gomes MPV, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy. Arch InternMed 2004;164:1965-76.
5. Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 2001;358:1427-9.
6. Conard J, Plu-Bureau G, Bahi N, et al. Progestogen-only contraception in women at high risk of venous thromboembolism. Contraception 2004;70:437-41.
7. Kuhnz W, Heuner A, Hümpel M, et al. In vivo conversion of norethisterone and norethisterone acetate to ethinyl estradiol in postmenopausal women. Contraception 1997;56:379-85.
8. Rosing J. Mechanisms of OC related thrombosis. Thromb Res 2005;115(Suppl):81-3.
9. Kuhl H. Effects of progestogens on haemostasis. Maturitas 1996;24:1-19.
10. Tans G, Bouma BN, Büller HR, et al. Changes of hemostatic variables during oral contraceptive use. Sem Vasc Med 2003;3:61-8.
11. Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H. Effect of four oral contraceptives on hemostatic parameters. Contraception 2004;70:97-106.
12. Herkert O, Kuhl H, Sandow J, Busse R, Schini-Kerth VB. Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression. Role of glucocorticoid receptor. Circulation 2001;104:2826-31.
13. Godsland IF. Biology: risk factor modification by OCs and HRT - lipids and lipoproteins. Maturitas 2004;47:299-303.
14. Wiegratz I, Lee JH, Kutschera E, et al. Effect of dienogest-containing oral contraceptives on lipid metabolism. Contraception 2002;65:223-9.
15. Clarkson TB, Appt SE. Controversis about HRT - lessons from monkey models. Maturitas 2005;51:64-74.
16. Tanis BC, van den Bosch AAJ, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. New Engl J Med 2001;345:1787-93.
17. Oelkers W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol 2004;217:255-61.
18. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002;53:688-708.
19. Machado RB, Tachotti F, Cavenague G, Maia E. Effects of two different oral contraceptives on total body water: a randomized study. Contraception 2006;73:344-7.
20. Wiegratz I, Kuhl H. Managing cutaneous manifestations of hyperandrogenic disorders. The role of oral contraceptives. Treat Endocrinol 2002;1:373-86.
21. Wiegratz I, Kutschera E, Lee JH, et al. Effect of four different oral contraceptives on various sex hormones and serum binding globulins. Contraception 2003;67:25-32.